Cite
MLA Citation
Jessica Spahn et al.. “Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models.” Journal for immunotherapy of cancer, vol. 3, no. 2, 2015, p. 1. http://access.bl.uk/ark:/81055/vdc_100080441580.0x0004d4